SAHPRA – review of certain products due to possible unacceptable carcinogen content. If The International Regulatory Agencies have started investigating active ingredients that have common N-Nitrosamine impurities – which develop during the manufacturing process of these active ingredients (and which are above-authorized levels and are potential carcinogens). The active ingredients include azilsartan, candesartan, eprosartan, irbesartan, losartan,Read more